Approval for acquisition of Fluence Pharma Private Limited and incorporation of a wholly owned subsidiary
As filed · Honasa Consumer Limited has informed the Exchange about approval for acquisition of Fluence Pharma Private Limited and incorporation of a wholly owned subsidiary
What happened
FactHonasa Consumer Limited's board has approved the acquisition of a 58% equity stake in Fluence Pharma Private Limited, which offers condition-specific OTC supplements, for an enterprise value of approximately ₹135 Crores. The company plans to acquire the remaining 42% stake in two tranches over the next 5-7 years. Additionally, the board has approved the incorporation of a wholly owned subsidiary, Honasa Health Private Limited, to manage its B2C nutraceuticals operations.
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.
Scale
- 5.9% of FY26 revenue
₹135 Cr stated in the filing against ₹2,305.41 Cr revenue (FY26, standalone)
Source: financial_facts · exchange_table
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
RevisedThe Derma Co. crossed INR 1,000 Cr in NSV ARR and entered the teens EBITDA club, making Honasa the only FMCG company in India to build two INR 1,000 Cr brands in the last ten years.
Q1FY27 witnessed highest-ever revenue of INR 785 Cr, growing 31.8% YoY, while EBITDA grew ~2X YoY to INR 110 Cr, with a healthy 14.1% margin.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Consideration and how it is funded
- Revenue and profit of the target
- Expected completion date
- Reginald can itself be Rs. 500 crore brand in the next 4-5 years that we acquired. (management committed by FY30)
- every year our goal will be to improve the margin profile by 100 basis points. (management committed by FY27)
Evidence
- Honasa Consumer Limited has informed the Exchange about approval for acquisition of Fluence Pharma Private Limited and incorporation of a wholly owned subsidiary(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- ACQUISITION base 74; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%